| Primary |
| Asthma |
57.8% |
| Drug Use For Unknown Indication |
15.1% |
| Product Used For Unknown Indication |
10.2% |
| Chronic Obstructive Pulmonary Disease |
7.0% |
| Cough |
1.7% |
| Emphysema |
1.6% |
| Bronchitis |
1.2% |
| Dyspnoea |
1.1% |
| Multiple Allergies |
0.7% |
| Eosinophilic Oesophagitis |
0.6% |
| Lung Disorder |
0.5% |
| Hypertension |
0.5% |
| Wheezing |
0.4% |
| Pain |
0.3% |
| Asthma Exercise Induced |
0.2% |
| Oesophagitis |
0.2% |
| Respiratory Tract Congestion |
0.2% |
| Anxiety |
0.2% |
| Blood Pressure |
0.2% |
| Bronchiectasis |
0.2% |
|
| Product Quality Issue |
20.4% |
| Pharmaceutical Product Complaint |
18.0% |
| Drug Ineffective |
11.4% |
| Wheezing |
7.2% |
| Throat Irritation |
6.1% |
| Dyspnoea |
5.3% |
| Dysphonia |
4.1% |
| Rash |
3.7% |
| Cough |
3.1% |
| Weight Increased |
3.0% |
| Asthma |
2.8% |
| Overdose |
2.1% |
| Vomiting |
1.9% |
| Oropharyngeal Pain |
1.7% |
| Malaise |
1.6% |
| Pneumonia |
1.6% |
| Urticaria |
1.6% |
| Death |
1.5% |
| Therapeutic Response Decreased |
1.5% |
| Pruritus |
1.4% |
|
| Secondary |
| Asthma |
39.1% |
| Product Used For Unknown Indication |
12.9% |
| Drug Use For Unknown Indication |
9.2% |
| Chronic Obstructive Pulmonary Disease |
8.7% |
| Hypersensitivity |
4.0% |
| Gastrooesophageal Reflux Disease |
3.0% |
| Diabetes Mellitus |
2.4% |
| Hypertension |
2.2% |
| Emphysema |
2.1% |
| Depression |
1.9% |
| Migraine |
1.7% |
| Sinus Congestion |
1.7% |
| Anxiety |
1.5% |
| Chest Pain |
1.5% |
| Bronchitis |
1.4% |
| Multiple Allergies |
1.4% |
| Sinusitis |
1.3% |
| Ill-defined Disorder |
1.3% |
| Muscle Spasms |
1.3% |
| Diabetic Neuropathy |
1.2% |
|
| Wheezing |
10.7% |
| Drug Ineffective |
8.0% |
| Dyspnoea |
7.6% |
| Memory Impairment |
7.6% |
| Product Quality Issue |
7.1% |
| Tremor |
6.7% |
| Pyrexia |
6.2% |
| Dysphonia |
4.4% |
| Muscle Spasms |
4.4% |
| Weight Increased |
4.4% |
| Oropharyngeal Pain |
4.0% |
| Pneumonia |
4.0% |
| Drug Hypersensitivity |
3.6% |
| Palpitations |
3.6% |
| Death |
3.1% |
| Hypothyroidism |
3.1% |
| Nervousness |
3.1% |
| Pharmaceutical Product Complaint |
3.1% |
| Asthma |
2.7% |
| Overdose |
2.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
20.6% |
| Asthma |
19.6% |
| Drug Use For Unknown Indication |
15.4% |
| Chronic Obstructive Pulmonary Disease |
10.2% |
| Hypertension |
5.4% |
| Pain |
3.5% |
| Gastrooesophageal Reflux Disease |
2.9% |
| Depression |
2.7% |
| Hypersensitivity |
2.7% |
| Rheumatoid Arthritis |
2.4% |
| Osteoporosis |
2.4% |
| Anxiety |
2.0% |
| Blood Cholesterol Increased |
1.4% |
| Emphysema |
1.4% |
| Arthritis |
1.4% |
| Diabetes Mellitus |
1.3% |
| Contraception |
1.2% |
| Insomnia |
1.2% |
| Prophylaxis |
1.2% |
| Atrial Fibrillation |
1.1% |
|
| Vomiting |
11.4% |
| Dyspnoea |
9.1% |
| Weight Decreased |
7.5% |
| Weight Increased |
7.5% |
| Wheezing |
6.6% |
| Pneumonia |
6.2% |
| Drug Ineffective |
5.9% |
| Urticaria |
4.2% |
| Asthma |
4.1% |
| Nausea |
4.1% |
| Tremor |
4.1% |
| Pulmonary Embolism |
3.8% |
| Product Quality Issue |
3.7% |
| Vision Blurred |
3.7% |
| Pain |
3.3% |
| Death |
3.3% |
| Somnolence |
3.0% |
| Pain In Extremity |
3.0% |
| Pyrexia |
2.8% |
| Suicidal Ideation |
2.7% |
|
| Interacting |
| Product Used For Unknown Indication |
40.0% |
| Pain |
14.0% |
| Asthma |
12.0% |
| Anxiety |
4.0% |
| Blood Cholesterol Increased |
4.0% |
| Constipation |
4.0% |
| Gastrooesophageal Reflux Disease |
4.0% |
| Hypothyroidism |
4.0% |
| Insomnia |
4.0% |
| Neuropathy Peripheral |
4.0% |
| Hypercholesterolaemia |
2.0% |
| Ill-defined Disorder |
2.0% |
| Multiple Sclerosis |
2.0% |
|
| Hypothyroidism |
36.4% |
| Unresponsive To Stimuli |
18.2% |
| Drug Interaction |
9.1% |
| Pain |
9.1% |
| Somnolence |
9.1% |
| Ulcer |
9.1% |
| Wound Infection |
9.1% |
|
